Superficial Femoral Artery

Jonathan L. Halperin, MD, FACC, FAHA, Chair Glenn N. Levine, MD, FACC, FAHA, Chair-Elect Sana M. Al-Khatib, MD, MHS, FACC… Expand

Background: Recent randomized trials investigating stent implantation compared with balloon angioplasty for treatment of… Expand

Purpose: To evaluate the long-term efficacy and integrity of the PROTÉGÉ EverFlex stent in superficial femoral artery (SFA… Expand

Flow-mediated dilatation (FMD) of the brachial and radial arteries is an important research tool for assessment of endothelial… Expand

Background— Endoluminal treatment of superficial femoral artery lesions is a matter of controversy. The present study was… Expand

BACKGROUND Because stent implantation for disease of the superficial femoral artery has been associated with high rates of late… Expand

PURPOSE To investigate further the safety and efficacy of the sirolimus-eluting S. M.A.R.T. Nitinol Self-expanding Stent by… Expand

Background—Stent implantation for obstructive femoropopliteal artery disease has been associated with poor long-term outcomes… Expand

PURPOSE Autogenous aortoiliac/femoral reconstruction with superficial femoral-popliteal veins (SFPVs) has been successfully used… Expand

OBJECTIVES This study attempted to assess whether coronary risk factors are associated with endothelial dysfunction in the… Expand